Prothena | PRTA - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 128.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Exelixis USD 235.91M 20.45M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Incyte USD 324.17M 59.7M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
MacroGenics USD -12.1M 30.74M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xoma USD -15.64M 5.56M 2024-09